Dendritic cells and CD8 T cell immunity in tumor microenvironment
C Fu, A Jiang - Frontiers in immunology, 2018 - frontiersin.org
Dendritic cells (DCs) play a central role in the regulation of the balance between CD8 T cell
immunity vs. tolerance to tumor antigens. Cross-priming, a process which DCs activate CD8 …
immunity vs. tolerance to tumor antigens. Cross-priming, a process which DCs activate CD8 …
DC-based vaccines for cancer immunotherapy
C Fu, L Zhou, QS Mi, A Jiang - Vaccines, 2020 - mdpi.com
As the sentinels of the immune system, dendritic cells (DCs) play a critical role in initiating
and regulating antigen-specific immune responses. Cross-priming, a process that DCs …
and regulating antigen-specific immune responses. Cross-priming, a process that DCs …
Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells
B Ruffell, D Chang-Strachan, V Chan, A Rosenbusch… - Cancer cell, 2014 - cell.com
Blockade of colony-stimulating factor-1 (CSF-1) limits macrophage infiltration and improves
response of mammary carcinomas to chemotherapy. Herein we identify interleukin (IL)-10 …
response of mammary carcinomas to chemotherapy. Herein we identify interleukin (IL)-10 …
DC-derived exosomes for cancer immunotherapy
Simple Summary Dendritic cells (DCs)-based cancer vaccines have not succeeded in
generating significant clinical responses despite their capacity to induce host anti-tumor …
generating significant clinical responses despite their capacity to induce host anti-tumor …
Synthetic immune niches for cancer immunotherapy
Cancer immunotherapy can successfully promote long-term anticancer immune responses,
although there is still only a limited number of patients who benefit from such treatment, and …
although there is still only a limited number of patients who benefit from such treatment, and …
Tertiary lymphoid structures in cancer: the double-edged sword role in antitumor immunity and potential therapeutic induction strategies
W Kang, Z Feng, J Luo, Z He, J Liu, J Wu… - Frontiers in …, 2021 - frontiersin.org
The complex tumor microenvironment (TME) plays a vital role in cancer development and
dramatically determines the efficacy of immunotherapy. Tertiary lymphoid structures (TLSs) …
dramatically determines the efficacy of immunotherapy. Tertiary lymphoid structures (TLSs) …
Dendritic cell-based vaccines against cancer: challenges, advances and future opportunities
As the most potent professional antigen presenting cells, dendritic cells (DCs) have the
ability to activate both naive CD4 and CD8 T cells. Recognized for their exceptional ability to …
ability to activate both naive CD4 and CD8 T cells. Recognized for their exceptional ability to …
Cell and tissue engineering in lymph nodes for cancer immunotherapy
In cancer, lymph nodes (LNs) coordinate tumor antigen presentation necessary for effective
antitumor immunity, both at the levels of local cellular interactions and tissue-level …
antitumor immunity, both at the levels of local cellular interactions and tissue-level …
Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment
AM Weinstein, L Chen, EA Brzana, PR Patil… - …, 2017 - Taylor & Francis
We have previously reported that direct injection of dendritic cells (DC) engineered to
express the Type-1 transactivator Tbet (ie, DC. Tbet) into murine tumors results in antitumor …
express the Type-1 transactivator Tbet (ie, DC. Tbet) into murine tumors results in antitumor …
Inducible tertiary lymphoid structures: promise and challenges for translating a new class of immunotherapy
S Aoyama, R Nakagawa, JJ Mulé… - Frontiers in …, 2021 - frontiersin.org
Tertiary lymphoid structures (TLS) are ectopically formed aggregates of organized
lymphocytes and antigen-presenting cells that occur in solid tissues as part of a chronic …
lymphocytes and antigen-presenting cells that occur in solid tissues as part of a chronic …